Ascendis Pharma

ASND

Market cap $12.5B

Overview Fund Trends Analyst Outlook Journalist POV

205.71 USD

--0.20

0.1%

At close Updated Oct 29, 4:00 PM EDT

Pre-market

After hours

203.00

--2.71

1.32%

1 day

-0.1%

5 days

1.8%

1 month

7.36%

3 months

25.96%

6 months

23.49%

Year to date

49.07%

1 year

62.27%

5 years

25.43%

10 years

1,049.22%

About: Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Employees: 1,017

Healthcare Biotechnology